News & Events

< Back to News Overview

Antipodean Pharmaceuticals Initiates Phase 2 Trial in Parkinsons's DiseaseCompany's Lead Compound MitoQ Targets Mitochondrial Dysfunction

25 / 05 / 2006

Please see the attached document(s) below.

Downloads

Download "Antipodean Pharmaceuticals Initiates Phase 2 Trial in Parkinsons's DiseaseCompany's Lead Compound MitoQ Targets Mitochondrial Dysfunction" [44B]